GlobeNewswire Inc | Dec 22, 2020 10:02AM EST

December 22, 2020

PHILADELPHIA, Dec. 22, 2020 (GLOBE NEWSWIRE) --

Kaskela Law LLC announces that it is investigating NantKwest, Inc. (NantKwest) (NASDAQ: NK) on behalf of the companys shareholders.

NantKwest shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 1585,or by email at skaskela@kaskelalaw.com or online at https://kaskelalaw.com/case/nantkwest-inc/, for additional information about this investigation and their legal rights and options.

On December 21, 2020, NantKwest announced that it had entered into an agreement to merge with ImmunityBio, a privately-heldcompany, in a stock-for-stock transaction. Following the closing of the transaction, NantKwest shareholders will only own approximately 28% of the combined company.

The investigation seeks to determine whether the transaction as structured is fair to NantKwest shareholders, and whether NantKwests officers and/or directors breached their fiduciary duties in connection with the agreement.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

CONTACT:

D. Seamus Kaskela, Esq.KASKELA LAW LLC18 Campus Boulevard, Suite 100Newtown Square, PA 19073(484) 258 1585skaskela@kaskelalaw.comwww.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.